RA0259

antibody from Oursmab

Targeting: FOLH1 FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0259

Provider

Oursmab

Product name

Rosopatamab (Biosimilar Reference Antibody) (FOLH1)

Antibody type

Monoclonal

Description

Rosopatamab is a humanized IgG1 monoclonal antibody targeting prostate-specific membrane antigen (PSMA). It binds to PSMA, a cell surface protein highly expressed in prostate cancer cells and tumor neovasculature. It is often used as a carrier for targeted delivery of radionuclides or cytotoxic agents in prostate cancer diagnosis and therapy.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Rosopatamab (Biosimilar Reference Antibody) (FOLH1)-RA0259-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Rosopatamab (Biosimilar Reference Antibody) (FOLH1)-RA0259 in a linear range of 3.91¨C125 ng/mL.